GrowLife, Inc. — Cyborg Score 4/10

Mixed
Functional mushroom cultivation and production

Strategic Profile

Since closing on the asset purchase of Bridgetown Mushrooms on January 7, 2023, GrowLife has expanded cultivation capacity by 133%, launched a new Mycology division and developed mushroom-based products. The company operates within four channels across the nation including retail, e-commerce, direct sales and distribution. GrowLife targets the emerging functional mushroom market segment, positioning itself as a producer of both consumer and wholesale mushroom products.

Cyborg Score Rationale

GrowLife operates in the growing functional mushroom market but remains micro-cap on OTC markets with limited liquidity and financial disclosure. The company shows operational expansion post-Bridgetown acquisition but lacks substantial revenue scale and trading volume typical of established players. Strategic pivot to mushrooms is sound, but execution risk is elevated given small headcount.

Top Insights

  • Strategic pivot from hydroponics distribution to vertically integrated mushroom cultivation and production reflects market demand for functional health products
  • Bridgetown Mushrooms acquisition (January 2023) provided operational platform with 10,000 sq ft facilities and 133% capacity expansion—foundational for scaling
  • Dual revenue model spanning retail storefronts, e-commerce, direct sales, and distribution channels reduces dependence on single channel
  • Limited public financial transparency and OTC status constrain institutional investor access and capital raising options

Named Competitors

  • Monterey Mushrooms — Fresh, dried, and vitamin D enriched mushroom products for retail, foodservice, and manufacturer sectors
  • Forage Hyperfoods — Functional mushroom wellness products including tinctures and supplements
  • Host Defense Mushrooms — Health supplements derived from mushrooms including capsules, powders, and liquid extracts
  • Hydrofarm — Indoor gardening and horticultural equipment supplier

Recent Developments

  • (January 2023) Completed acquisition of Bridgetown Mushrooms in Portland, Oregon with 10,000 sq ft cultivation facilities
  • (January 2023) Expanded cultivation capacity by 133% and launched new Mycology division
  • (October 2023) Released Kind Coffee Co-Op in collaboration with RPG Coffee and Kindness.org
  • (August 2023) Announced plans to achieve EBITDA positive status before end of 2023

Open the full interactive GrowLife, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →